Home ›
Investor Directory ›
Biotechnology ›
Series A
Active Series A Biotechnology Investors (2026)
7 investors currently writing series a checks in Biotechnology. Synthesized from live platform activity · updated October 2026.
Raising capital in the Biotechnology space requires finding partners who understand your specific market dynamics. The investors listed here are actively deploying capital and looking for high-growth opportunities with defensible competitive advantages. Series A investors are focused on scaling. They expect proven business models, strong unit economics, and a clear path to dominating a market segment.
Sector: Biotechnology
Stage: Series A
+ Geography
+ Check size
RW
Rob Wilder
FTW Ventures is an early-stage venture fund focused on food and agricultural technology that deploys capital to support founders solving sys...
FT
Finian Tan
Vickers Venture Partners, founded by Dr. Finian Tan in 2005, invests in early-stage deep-tech companies and life sciences ventures globally...
Avijeet Alagathi, CFA
Shastra VC is an early-stage venture fund backing science- and engineering-led companies in deeptech, artificial intelligence, climate techn...
Tom Williams
Tom Williams founded Heron Rock Capital as an exclusively first-check investor platform backing exceptional founders and difficult ideas bef...
Vikas Verma
Avaana Capital invests in deep tech innovators solving critical challenges across energy, supply chains, food systems, and advanced material...
Ashwin Raguraman
Ashwin Raguraman invests in early-stage deep tech startups originating from India that address global markets. Through Bharat Innovation Fun...
BS
Bharathwaj Sridhar
Backs science-led deep-tech and life-sciences founders from seed through Series B
Sign up to view all investors
Join AngelLinx for free to access our full directory of active investors.
Sign up for free
Already have an account? Log in
Related
See which of these 7 fit your startup
Free · under a minute